New drug aims to wipe out superbugs in the gut
Disease control
ENROLLING_BY_INVITATION
This study tests a treatment called BM111 to remove two types of antibiotic-resistant bacteria (CRE and VRE) from the gut of healthy carriers. About 38 adults who carry these bacteria but do not have an active infection will receive either BM111 or a placebo. The goal is to see i…
Phase: NA • Sponsor: BioMe Inc. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC